GTBPVSLGO• 12 Months (Normalized)
GTBP vs LGO (GT Biopharma Inc. vs Largo Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+854.62%
GT Biopharma Inc.
Normalized Baseline0.00%
LGO Performance $0.47
-69.77%
Largo Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+924.39 pts
GTBP outperforming by 924.39 percentage points
GTBPLGO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP LGO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | GTBP Price | GTBP Gain (%) | LGO Price | LGO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +854.62% | $0.47 | -69.77% | +924.39% |
| Sep 29, 2026 | $6.88 | +975.90% | $- | - | |
| Sep 28, 2026 | $6.80 | +964.16% | $- | - | |
| Sep 25, 2026 | $6.89 | +978.25% | $0.53 | -66.24% | +1044.49% |
| Sep 24, 2026 | $6.83 | +968.86% | $0.69 | -56.05% | +1024.91% |
| Sep 23, 2026 | $7.10 | +1011.11% | $0.73 | -53.50% | +1064.61% |
| Sep 22, 2026 | $- | $0.65 | -58.60% | - | |
| Sep 21, 2026 | $7.18 | +1023.63% | $0.63 | -59.87% | +1083.50% |
| Sep 18, 2026 | $7.16 | +1020.50% | $0.65 | -58.60% | +1079.10% |
| Sep 17, 2026 | $7.49 | +1072.14% | $0.68 | -56.69% | +1128.83% |
| Sep 16, 2026 | $7.81 | +1122.22% | $0.66 | -57.96% | +1180.18% |
| Sep 15, 2026 | $9.00 | +1308.45% | $0.69 | -56.05% | +1364.50% |
| Sep 14, 2026 | $11.63 | +1720.03% | $0.68 | -56.69% | +1776.72% |
| Sep 11, 2026 | $8.61 | +1247.42% | $0.68 | -56.69% | +1304.11% |
| Sep 10, 2026 | $6.18 | +867.14% | $0.69 | -56.05% | +923.19% |
Page 1 of 17